Dale R. Pfost PhD

Dale R. Pfost, PhD Director, Co-founder, and CEO, Founding CEO of five biotechnology companies achieved 3 IPOs, 3 trade-sales, and 3 companies with market capitalizations of over $2 billion: Infinite, producer of Biomek, acquired by SmithKline Beckman (1984), Oxford GlycoSciences (IPO 1988), Orchid Biosciences (IPO 2000), Acuity Pharmaceuticals (now OPKO Health, 2007), Receptor BioLogix (sold 2009), NuMe Health (founded 2009, now MBT). Currently is the US General Partner of London-based Advent Life Sciences—a venture capital group focused entirely on life science investments in the US and Europe.